Survival after radiofrequency ablation and/or chemotherapy for lung cancer and pulmonary metastases: a systematic review and meta-analysis

BACKGROUND: Radiofrequency ablation (RFA) and chemotherapy are used to treat lung cancer or pulmonary metastases, but no direct comparison of overall survival (OS) has been published. The present study aimed to assess the OS of RFA and/or chemotherapy in patients with lung cancer or pulmonary metast...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Ziyi, Lyu, Xia, Yang, Huilin, Wang, Bingbing, Xu, Dan, Huo, Lingyi, Zhang, Runzi, Huang, Yingjun, Diao, Benshu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587578/
https://www.ncbi.nlm.nih.gov/pubmed/37869011
http://dx.doi.org/10.3389/fimmu.2023.1240149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587578/
https://www.ncbi.nlm.nih.gov/pubmed/37869011
http://dx.doi.org/10.3389/fimmu.2023.1240149

Ejemplares similares